Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is behind schedule. He had set a 2024 timeframe for delivery. The ...

U.S. FDA approves Biocon’s insulin Semglee It can be used for medicines that do not need to be authorised via the centralised procedure and have not already been authorised in any member state ...

The action was brought on behalf of Jaime Vial and other heirs of a Chilean man who owned stocks in companies incorporated in Delaware such as Citigroup Inc. and Hilton Hotels Corp. The Office of ...

Nearly 100 live samples of the deadly Hendra virus have been lost in a biosecurity bungle at a state-run Queensland laboratory. An investigation has been launched after it was revealed 323 virus ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...